# Epigenomics AG (EPGNF)

> 医疗保健 · DE · 以 EUR 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/EPGNF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | € 360.0K | € -4.74M | € -6.06M | € 11.89M | € -8.02M |
| 2022 | € 529.6K | € -13.13M | € -14.62M | € 841.0K | € 10.17M |
| 2021 | € 7.40M | € -2.90M | € -4.99M | € 460.0K | € 22.12M |
| 2020 | € 1.05M | € -14.63M | € -12.01M | € 683.0K | € 3.86M |
| 2019 | € 1.40M | € -21.24M | € -17.01M | € 913.0K | € 9.63M |
| 2018 | € 1.94M | € -16.06M | € -13.23M | € 0 | € 18.61M |
| 2017 | € 2.39M | € -13.14M | € -13.21M | € 6.54M | € 10.58M |
| 2016 | € 5.47M | € -14.53M | € -18.94M | € 0 | € 14.42M |
| 2015 | € 2.74M | € -11.82M | € -10.97M | € 1.07M | € 7.10M |
| 2014 | € 1.99M | € -11.68M | € -10.68M | € 1.93M | € 6.11M |
| 2013 | € 2.09M | € -9.76M | € -8.59M | € 1.93M | € 6.46M |
| 2012 | € 1.38M | € -16.19M | € -14.53M | € 0 | € 4.16M |
| 2011 | € 1.95M | € -21.14M | € -16.62M | € 0 | € 16.19M |
| 2010 | € 2.49M | € -16.01M | € -14.19M | € 9.0K | € 31.30M |
| 2009 | € 6.07M | € -14.58M | € -15.62M | € 37.0K | € 12.08M |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | -1.48 |
| 总负债 / 股东权益 | -2.60 |
| 流动比率 | 9.03 |

## 其他视图

- [指标](https://sponda.capital/zh/EPGNF.md)
- [图表](https://sponda.capital/zh/EPGNF/charts.md)
- [对比](https://sponda.capital/zh/EPGNF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-27。